FDA Sets Priority Review for Fruquintinib as ASCO Data Confi

The therapy is designed to target multiple receptors and could address an unmet need in metastatic colorectal cancer.

Related Keywords

Australia , United States , Japan , China , American , Chinese , Jemala Colorecal , Awny Farajallah , Tus Fruquintinib , American Society Of Clinical Oncology Annual Meeting , Takeda Pharmaceuticals , Vanderbilt University Medical Center , Devices Agency , European Medicines Agency , Global Medical Affairs , Us Preventive Services Task , European Society Of Medical Oncology , Clinical Oncology Annual Meeting , Evidence Based Oncology , European Society , Medical Oncology , Medical Devices Agency , Prescription Drug User Fee , Services Task Force , New Drug Application , Published June , Vanderbilt University Medical , Colorectal Cancer , Vegf , Fruquintinib , Pasco , Vanderbilt ,